25 XP   0   0   10

Sanofi SA
Buy, Hold or Sell?

Let's analyse Sanofi together

PenkeI guess you are interested in Sanofi SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sanofi SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sanofi SA

I send you an email if I find something interesting about Sanofi SA.

Quick analysis of Sanofi (30 sec.)










What can you expect buying and holding a share of Sanofi? (30 sec.)

What is your share worth?

Current worth
€0.00
Expected worth in 1 year
€0.00
How sure are you?

+ What do you gain per year?

Total Gains per Share
€0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
€86.61
Expected price per share
€83.32 - €96.48
How sure are you?
50%

1. Valuation of Sanofi (5 min.)




Live pricePrice per Share (EOD)

€86.61

2. Growth of Sanofi (5 min.)




Is Sanofi growing?

Current yearPrevious yearGrowGrow %
How rich?$73.1b$73.1b0.000.0%

How much money is Sanofi making?

Current yearPrevious yearGrowGrow %
Making money$8.9b$6.6b$2.2b25.7%
Net Profit Margin0.0%15.9%--

How much money comes from the company's main activities?

3. Financial Health of Sanofi (5 min.)




What can you expect buying and holding a share of Sanofi? (5 min.)

Welcome investor! Sanofi's management wants to use your money to grow the business. In return you get a share of Sanofi.

What can you expect buying and holding a share of Sanofi?

First you should know what it really means to hold a share of Sanofi. And how you can make/lose money.

Speculation

The Price per Share of Sanofi is €86.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sanofi.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sanofi, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.00.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash.
Based on historical numbers we can estimate the returns while holding a share of Sanofi.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share
Usd Dividend Per Share
Usd Total Gains Per Share
Usd Price Per Share96.37-96.37-94.16-90.02-87.79-
Price to Earnings Ratio0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio

When do you get the money?

Usd Investment
$.00
Usd Price Per Share92.199683
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share--
Usd Book Value Change Per Share--
Usd Total Gains Per Share--
Gains per Quarter (10 shares)--
Gains per Year (10 shares)--
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1---10---10
2---10---10
3---10---10
4---10---10
5---10---10
6---10---10
7---10---10
8---10---10
9---10---10
10---10---10

Fundamentals of Sanofi

About Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2024-04-17 22:35:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry

1.1. Profitability of Sanofi SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sanofi earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Sanofi to the  industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sanofi SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY15.9%-15.9%
TTM-5Y13.7%-13.7%
5Y13.7%10Y15.3%-1.6%
1.1.2. Return on Assets

Shows how efficient Sanofi is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sanofi to the  industry mean.
  • 7.0% Return on Assets means that Sanofi generated €0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sanofi SA:

  • The MRQ is 7.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.0%TTM7.0%0.0%
TTM7.0%YOY5.2%+1.8%
TTM7.0%5Y5.8%+1.1%
5Y5.8%10Y6.3%-0.4%
1.1.3. Return on Equity

Shows how efficient Sanofi is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sanofi to the  industry mean.
  • 12.2% Return on Equity means Sanofi generated €0.12 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sanofi SA:

  • The MRQ is 12.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.2%TTM12.2%0.0%
TTM12.2%YOY9.1%+3.1%
TTM12.2%5Y10.6%+1.6%
5Y10.6%10Y11.2%-0.7%

1.2. Operating Efficiency of Sanofi SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sanofi is operating .

  • Measures how much profit Sanofi makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sanofi to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sanofi SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21.9%-21.9%
TTM-5Y15.4%-15.4%
5Y15.4%10Y12.9%+2.6%
1.2.2. Operating Ratio

Measures how efficient Sanofi is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sanofi SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.313-0.313
TTM-5Y0.255-0.255
5Y0.25510Y0.266-0.011

1.3. Liquidity of Sanofi SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sanofi is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.42 means the company has €1.42 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sanofi SA:

  • The MRQ is 1.423. The company is just able to pay all its short-term debts.
  • The TTM is 1.423. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.423TTM1.4230.000
TTM1.423YOY1.439-0.017
TTM1.4235Y1.490-0.068
5Y1.49010Y1.526-0.036
1.3.2. Quick Ratio

Measures if Sanofi is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sanofi to the  industry mean.
  • A Quick Ratio of 0.45 means the company can pay off €0.45 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sanofi SA:

  • The MRQ is 0.448. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.448. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.448TTM0.4480.000
TTM0.448YOY0.934-0.486
TTM0.4485Y0.916-0.467
5Y0.91610Y0.952-0.036

1.4. Solvency of Sanofi SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sanofi assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sanofi to industry mean.
  • A Debt to Asset Ratio of 0.43 means that Sanofi assets are financed with 42.9% credit (debt) and the remaining percentage (100% - 42.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sanofi SA:

  • The MRQ is 0.429. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.429. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.429TTM0.4290.000
TTM0.429YOY0.4290.000
TTM0.4295Y0.451-0.022
5Y0.45110Y0.446+0.005
1.4.2. Debt to Equity Ratio

Measures if Sanofi is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sanofi to the  industry mean.
  • A Debt to Equity ratio of 75.1% means that company has €0.75 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sanofi SA:

  • The MRQ is 0.751. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.751. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.751TTM0.7510.000
TTM0.751YOY0.7510.000
TTM0.7515Y0.824-0.073
5Y0.82410Y0.806+0.018

2. Market Valuation of Sanofi SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Sanofi generates.

  • Above 15 is considered overpriced but always compare Sanofi to the  industry mean.
  • A PE ratio of 0.00 means the investor is paying €0.00 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sanofi SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sanofi SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sanofi is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.00 means the investor is paying €0.00 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sanofi SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sanofi SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share----0%-0%-0%-0%
Current Ratio--1.4231.4230%1.439-1%1.490-5%1.526-7%
Debt To Asset Ratio--0.4290.4290%0.4290%0.451-5%0.446-4%
Debt To Equity Ratio--0.7510.7510%0.7510%0.824-9%0.806-7%
Eps----0%-0%-0%-0%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap----0%-0%-0%-0%
Net Profit Margin----0%0.159-100%0.137-100%0.153-100%
Operating Margin----0%0.219-100%0.154-100%0.129-100%
Operating Ratio----0%0.313-100%0.255-100%0.266-100%
Pb Ratio----0%-0%-0%-0%
Pe Ratio----0%-0%-0%-0%
Price Per Share86.605-5%90.52090.5200%88.451+2%84.553+7%82.460+10%
Price To Free Cash Flow Ratio----0%-0%-0%-0%
Quick Ratio--0.4480.4480%0.934-52%0.916-51%0.952-53%
Return On Assets--0.0700.0700%0.052+35%0.058+19%0.063+11%
Return On Equity--0.1220.1220%0.091+35%0.106+15%0.112+9%
Usd Book Value--73117792600.00073117792600.0000%73117792600.0000%67767751760.000+8%66776680133.333+9%
Usd Book Value Per Share----0%-0%-0%-0%
Usd Eps----0%-0%-0%-0%
Usd Free Cash Flow--9496232000.0009496232000.0000%9627177800.000-1%7377890920.000+29%7110463400.000+34%
Usd Market Cap----0%-0%-0%-0%
Usd Price Per Share92.200-5%96.36896.3680%94.165+2%90.015+7%87.787+10%
Usd Profit--8911766600.0008911766600.0000%6625005800.000+35%7239280000.000+23%7526012266.667+18%
Usd Revenue----0%41705705000.000-100%31906487840.000-100%33015552633.333-100%
 EOD+1 -1MRQTTM+0 -0YOY+5 -75Y+9 -610Y+9 -6

3.2. Fundamental Score

Let's check the fundamental score of Sanofi SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.448
Current Ratio (MRQ)Greater than11.423
Debt to Asset Ratio (MRQ)Less than10.429
Debt to Equity Ratio (MRQ)Less than10.751
Return on Equity (MRQ)Greater than0.150.122
Return on Assets (MRQ)Greater than0.050.070
Total4/8 (50.0%)

3.3. Technical Score

Let's check the technical score of Sanofi SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.971
Ma 20Greater thanMa 5088.037
Ma 50Greater thanMa 10087.720
Ma 100Greater thanMa 20088.954
OpenGreater thanClose86.200
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Assets0
Total Current Assets34,111,000
Long-term Assets0
Total Current Assets
Net Receivables 10,746,000
Inventory 8,960,000
Other Current Assets 955,000
Total Current Assets  (as reported)34,111,000
Total Current Assets  (calculated)20,661,000
+/- 13,450,000
Long-term Assets
Property Plant Equipment 11,684,000
Long-term Assets  (as reported)0
Long-term Assets  (calculated)11,684,000
+/- 11,684,000

Liabilities & Shareholders' Equity

Total Current Liabilities23,974,000
Long-term Liabilities0
Total Stockholder Equity0
Total Current Liabilities
Accounts payable 6,813,000
Other Current Liabilities 10,132,000
Total Current Liabilities  (as reported)23,974,000
Total Current Liabilities  (calculated)16,945,000
+/- 7,029,000
Long-term Liabilities
Deferred Long Term Liability 6,226,000
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)6,226,000
+/- 6,226,000
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Net Tangible Assets 9,478,000
Net Working Capital 10,137,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
99,813,000
111,408,000
112,736,000
114,413,000
120,242,000
0
0120,242,000114,413,000112,736,000111,408,00099,813,000
   > Total Current Assets 
26,354,000
24,647,000
28,936,000
33,786,000
30,653,000
34,111,000
34,111,00030,653,00033,786,00028,936,00024,647,00026,354,000
       Cash And Cash Equivalents 
10,315,000
6,264,000
8,726,000
13,915,000
10,098,000
0
010,098,00013,915,0008,726,0006,264,00010,315,000
       Short-term Investments 
0
199,000
426,000
0
0
0
000426,000199,0000
       Net Receivables 
7,216,000
9,345,000
10,083,000
9,953,000
9,787,000
10,746,000
10,746,0009,787,0009,953,00010,083,0009,345,0007,216,000
       Inventory 
6,818,000
7,477,000
7,994,000
8,352,000
8,715,000
8,960,000
8,960,0008,715,0008,352,0007,994,0007,477,0006,818,000
       Other Current Assets 
2,005,000
401,000
935,000
1,041,000
1,427,000
955,000
955,0001,427,0001,041,000935,000401,0002,005,000
   > Long-term Assets 000000
       Property Plant Equipment 
9,579,000
9,651,000
11,017,000
10,563,000
11,976,000
11,684,000
11,684,00011,976,00010,563,00011,017,0009,651,0009,579,000
       Goodwill 
40,264,000
44,235,000
44,519,000
0
0
0
00044,519,00044,235,00040,264,000
       Intangible Assets 
13,080,000
21,889,000
16,572,000
62,705,000
69,463,000
0
069,463,00062,705,00016,572,00021,889,00013,080,000
> Total Liabilities 
41,743,000
52,532,000
53,802,000
51,307,000
51,561,000
0
051,561,00051,307,00053,802,00052,532,00041,743,000
   > Total Current Liabilities 
15,463,000
17,376,000
20,387,000
19,280,000
21,295,000
23,974,000
23,974,00021,295,00019,280,00020,387,00017,376,00015,463,000
       Short-term Debt 
237,000
249,000
305,000
0
0
0
000305,000249,000237,000
       Accounts payable 
0
5,041,000
5,313,000
5,295,000
6,180,000
6,813,000
6,813,0006,180,0005,295,0005,313,0005,041,0000
       Other Current Liabilities 
0
7,320,000
7,918,000
8,597,000
9,108,000
10,132,000
10,132,0009,108,0008,597,0007,918,0007,320,0000
   > Long-term Liabilities 000000
       Other Liabilities 
0
12,990,000
11,895,000
11,205,000
10,954,000
10,835,000
10,835,00010,954,00011,205,00011,895,00012,990,0000
       Deferred Long Term Liability 
0
4,744,000
2,334,000
6,092,000
7,730,000
6,226,000
6,226,0007,730,0006,092,0002,334,0004,744,0000
> Total Stockholder Equity
58,070,000
58,876,000
58,934,000
63,106,000
68,681,000
0
068,681,00063,106,00058,934,00058,876,00058,070,000
   Common Stock
2,508,000
2,495,000
2,508,000
2,518,000
2,527,000
2,522,000
2,522,0002,527,0002,518,0002,508,0002,495,0002,508,000
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 
52,862,000
53,106,000
51,927,000
0
0
0
00051,927,00053,106,00052,862,000
   Treasury Stock000-9,000-153,000-14,000
   Other Stockholders Equity 
2,714,000
56,521,000
56,410,000
60,931,000
66,561,000
72,843,000
72,843,00066,561,00060,931,00056,410,00056,521,0002,714,000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-0
Operating Income00
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense00
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income0
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)00
EBIT - interestExpense = 11,038,000
2,006,000
0
Interest Expense0
Earnings Before Interest and Taxes (EBIT)11,038,0000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax0
Tax Provision-0
Net Income From Continuing Ops00
Net Income0
Net Income Applicable To Common Shares8,371,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,587,000
Total Other Income/Expenses Net00
 

Technical Analysis of Sanofi
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sanofi. The general trend of Sanofi is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sanofi's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sanofi SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 92.32 < 94.27 < 96.48.

The bearish price targets are: 84.94 > 83.41 > 83.32.

Tweet this
Sanofi SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sanofi SA. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sanofi SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sanofi SA. The current macd is -0.61837822.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sanofi price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sanofi. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sanofi price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sanofi SA Daily Moving Average Convergence/Divergence (MACD) ChartSanofi SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sanofi SA. The current adx is 11.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sanofi shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sanofi SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sanofi SA. The current sar is 90.27.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sanofi SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sanofi SA. The current rsi is 44.97. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Sanofi SA Daily Relative Strength Index (RSI) ChartSanofi SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sanofi SA. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sanofi price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sanofi SA Daily Stochastic Oscillator ChartSanofi SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sanofi SA. The current cci is -83.23081432.

Sanofi SA Daily Commodity Channel Index (CCI) ChartSanofi SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sanofi SA. The current cmo is -10.05689295.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sanofi SA Daily Chande Momentum Oscillator (CMO) ChartSanofi SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sanofi SA. The current willr is -77.02596381.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sanofi is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sanofi SA Daily Williams %R ChartSanofi SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sanofi SA.

Sanofi SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sanofi SA. The current atr is 1.57093117.

Sanofi SA Daily Average True Range (ATR) ChartSanofi SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sanofi SA. The current obv is -17,505,603.

Sanofi SA Daily On-Balance Volume (OBV) ChartSanofi SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sanofi SA. The current mfi is 13.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Sanofi SA Daily Money Flow Index (MFI) ChartSanofi SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sanofi SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sanofi SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sanofi SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.971
Ma 20Greater thanMa 5088.037
Ma 50Greater thanMa 10087.720
Ma 100Greater thanMa 20088.954
OpenGreater thanClose86.200
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sanofi with someone you think should read this too:
  • Are you bullish or bearish on Sanofi? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sanofi? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sanofi SA

I send you an email if I find something interesting about Sanofi SA.


Comments

How you think about this?

Leave a comment

Stay informed about Sanofi SA.

Receive notifications about Sanofi SA in your mailbox!